Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
- PMID: 33975548
- PMCID: PMC8111051
- DOI: 10.1186/s12879-021-06130-7
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Erratum for
-
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.BMC Infect Dis. 2021 Apr 10;21(1):337. doi: 10.1186/s12879-021-06045-3. BMC Infect Dis. 2021. PMID: 33838657 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical